|
1
|
Liang XH, Kleeman LK, Jiang HH, Gordon G,
Goldman JE, Berry G, Herman B and Levine B: Protection against
fatal Sindbis virus encephalitis by beclin, a novel
Bcl-2-interacting protein. J Virol. 72:8586–8596. 1998.PubMed/NCBI
|
|
2
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Funderburk SF, Wang QJ and Yue Z: The
Beclin 1-VPS34 complex–at the crossroads of autophagy and beyond.
Trends Cell Biol. 20:355–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Russell RC, Tian Y, Yuan H, Park HW, Chang
YY, Kim J, Kim H, Neufeld TP, Dillin A and Guan KL: ULK1 induces
autophagy by phosphorylating Beclin-1 and activating VPS34 lipid
kinase. Nat Cell Biol. 15:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang RC, Wei Y, An Z, Zou Z, Xiao G,
Bhagat G, White M, Reichelt J and Levine B: Akt-mediated regulation
of autophagy and tumorigenesis through Beclin 1 phosphorylation.
Science. 338:956–959. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aita VM, Liang XH, Murty VV, Pincus DL, Yu
W, Cayanis E, Kalachikov S, Gilliam TC and Levine B: Cloning and
genomic organization of beclin 1, a candidate tumor suppressor gene
on chromosome 17q21. Genomics. 59:59–65. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He Y, Zhao X, Subahan NR, Fan L, Gao J and
Chen H: The prognostic value of autophagy-related markers beclin-1
and microtubule-associated protein light chain 3B in cancers: A
systematic review and meta-analysis. Tumour Biol. 35:7317–7326.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cicchini M, Chakrabarti R, Kongara S,
Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y and Karantza
V: Autophagy regulator BECN1 suppresses mammary tumorigenesis
driven by WNT1 activation and following parity. Autophagy.
10:2036–2052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lozy F, Cai-McRae X, Teplova I, Price S,
Reddy A, Bhanot G, Ganesan S, Vazquez A and Karantza V: ERBB2
overexpression suppresses stress-induced autophagy and renders
ERBB2-induced mammary tumorigenesis independent of monoallelic
Becn1 loss. Autophagy. 10:662–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huo Y, Cai H, Teplova I, Bowman-Colin C,
Chen G, Price S, Barnard N, Ganesan S, Karantza V, White E, et al:
Autophagy opposes p53-mediated tumor barrier to facilitate
tumorigenesis in a model of PALB2-associated hereditary breast
cancer. Cancer Discov. 3:894–907. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong C, Bauvy C, Tonelli G, Yue W,
Delomenie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V,
Tharinger H, et al: Beclin 1 and autophagy are required for the
tumorigenicity of breast cancer stem-like/progenitor cells.
Oncogene. 32:2261–2272. 2272e 2261–2211. 2013. View Article : Google Scholar :
|
|
15
|
Cong L, Ran FA, Cox D, Lin S, Barretto R,
Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al: Multiplex
genome engineering using CRISPR/Cas systems. Science. 339:819–823.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wright AV, Nuñez JK and Doudna JA: Biology
and applications of CRISPR Systems: Harnessing nature's toolbox for
genome engineering. Cell. 164:29–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sánchez-Rivera FJ and Jacks T:
Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev
Cancer. 15:387–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shalem O, Sanjana NE and Zhang F:
High-throughput functional genomics using CRISPR-Cas9. Nat Rev
Genet. 16:299–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Lehmann BD, Jovanović B, Chen X, Estrada
MV, Johnson KN, Shyr Y, Moses HL, Sanders ME and Pietenpol JA:
Refinement of triple-negative breast cancer molecular subtypes:
Implications for neoadjuvant chemotherapy selection. PLoS One.
11:e01573682016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maire V, Némati F, Richardson M,
Vincent-Salomon A, Tesson B, Rigaill G, Gravier E, Marty-Prouvost
B, De Koning L, Lang G, et al: Polo-like kinase 1: A potential
therapeutic option in combination with conventional chemotherapy
for the management of patients with triple-negative breast cancer.
Cancer Res. 73:813–823. 2013. View Article : Google Scholar
|
|
22
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
23
|
Maycotte P, Gearheart CM, Barnard R, Aryal
S, Mulcahy Levy JM, Fosmire SP, Hansen RJ, Morgan MJ, Porter CC,
Gustafson DL, et al: STAT3-mediated autophagy dependence identifies
subtypes of breast cancer where autophagy inhibition can be
efficacious. Cancer Res. 74:2579–2590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mariño G, Niso-Santano M, Baehrecke EH and
Kroemer G: Self-consumption: The interplay of autophagy and
apoptosis. Nat Rev Mol Cell Biol. 15:81–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang MC, Wu AG, Huang YZ, Shao GL, Ji SF,
Wang RW, Yuan HJ, Fan XL, Zheng LH and Jiao QL: Autophagic
regulation of cell growth by altered expression of Beclin 1 in
triple-negative breast cancer. Int J Clin Exp Med. 8:7049–7058.
2015.PubMed/NCBI
|
|
26
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qadir MA, Kwok B, Dragowska WH, To KH, Le
D, Bally MB and Gorski SM: Macroautophagy inhibition sensitizes
tamoxifen-resistant breast cancer cells and enhances mitochondrial
depolarization. Breast Cancer Res Treat. 112:389–403. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu Y, Chen T, Li G, Xu C, Xu Z, Zhang J,
He K, Zheng L, Guan Z, Su X, et al: Lower Beclin 1 downregulates
HER2 expression to enhance tamoxifen sensitivity and predicts a
favorable outcome for ER positive breast cancer. Oncotarget.
8:52156–52177. 2016.
|
|
29
|
Han J, Hou W, Lu C, Goldstein LA, Stolz
DB, Watkins SC and Rabinowich H: Interaction between Her2 and
Beclin-1 proteins underlies a new mechanism of reciprocal
regulation. J Biol Chem. 288:20315–20325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kohrman AQ and Matus DQ: Divide or
conquer: Cell cycle regulation of invasive behavior. Trends Cell
Biol. 27:12–25. 2017. View Article : Google Scholar
|
|
31
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Ji X, Wang D, Liu J and Zhang X:
Autophagic flux is highly active in early mitosis and
differentially regulated throughout the cell cycle. Oncotarget.
7:39705–39718. 2016.PubMed/NCBI
|
|
33
|
Frémont S, Gérard A, Galloux M, Janvier K,
Karess RE and Berlioz-Torrent C: Beclin-1 is required for
chromosome congression and proper outer kinetochore assembly. EMBO
Rep. 14:364–372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park JM, Tougeron D, Huang S, Okamoto K
and Sinicrope FA: Beclin 1 and UVRAG confer protection from
radiation-induced DNA damage and maintain centrosome stability in
colorectal cancer cells. PLoS One. 9:e1008192014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu
YF, Xu J, Long J, Liu L, Ni QX, et al: Epithelial-mesenchymal
transition in pancreatic cancer: Is it a clinically significant
factor. Biochim Biophys Acta. 1855:43–49. 2015.
|
|
37
|
Gumbiner BM: Cell adhesion: The molecular
basis of tissue architecture and morphogenesis. Cell. 84:345–357.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu CY, Lin HH, Tang MJ and Wang YK:
Vimentin contributes to epithelial-mesenchymal transition cancer
cell mechanics by mediating cytoskeletal organization and focal
adhesion maturation. Oncotarget. 6:15966–15983. 2015.PubMed/NCBI
|
|
40
|
Fukagawa A, Ishii H, Miyazawa K and Saitoh
M: δEF1 associates with DNMT1 and maintains DNA methylation of the
E-cadherin promoter in breast cancer cells. Cancer Med. 4:125–135.
2015. View Article : Google Scholar
|
|
41
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ding L, Lu Z, Lu Q and Chen YH: The
claudin family of proteins in human malignancy: A clinical
perspective. Cancer Manag Res. 5:367–375. 2013.PubMed/NCBI
|
|
43
|
Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N
and Xu B: A CLDN1-negative phenotype predicts poor prognosis in
triple-negative breast cancer. PLoS One. 9:e1127652014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao X, Zou Y, Gu Q, Zhao G, Gray H,
Pfeffer LM and Yue J: Lentiviral vector mediated Claudin1 silencing
inhibits epithelial to mesenchymal transition in breast cancer
cells. Viruses. 7:2965–2979. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Martínez-Estrada OM, Cullerés A, Soriano
FX, Peinado H, Bolós V, Martínez FO, Reina M, Cano A, Fabre M and
Vilaró S: The transcription factors Slug and Snail act as
repressors of Claudin-1 expression in epithelial cells. Biochem J.
394:449–457. 2006. View Article : Google Scholar :
|
|
46
|
Li Z, Chen B, Wu Y, Jin F, Xia Y and Liu
X: Genetic and epigenetic silencing of the beclin 1 gene in
sporadic breast tumors. BMC Cancer. 10:982010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan
J and Wang L: The significance of expression of autophagy-related
gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol.
32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Laddha SV, Ganesan S, Chan CS and White E:
Mutational landscape of the essential autophagy gene BECN1 in human
cancers. Mol Cancer Res. 12:485–490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Correa RJ, Valdes YR, Shepherd TG and
DiMattia GE: Beclin-1 expression is retained in high-grade serous
ovarian cancer yet is not essential for autophagy induction in
vitro. J Ovarian Res. 8:522015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y
and Zheng HC: Aberrant Beclin 1 expression is closely linked to
carcinogenesis, differentiation, progression, and prognosis of
ovarian epithelial carcinoma. Tumour Biol. 35:1955–1964. 2014.
View Article : Google Scholar
|
|
51
|
Shen Y, Li DD, Wang LL, Deng R and Zhu XF:
Decreased expression of autophagy-related proteins in malignant
epithelial ovarian cancer. Autophagy. 4:1067–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY,
Xing YN, Takahashi H, Takano Y and Zheng HC: Beclin 1 expression is
an independent prognostic factor for gastric carcinomas. Tumour
Biol. 34:1071–1083. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu S, Li G, Wang Z, Wang Z, Chen C, Cai S
and He Y: Low expression of MAP1LC3B, associated with low Beclin-1,
predicts lymph node metastasis and poor prognosis of gastric
cancer. Tumour Biol. 37:15007–15017. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fei B, Ji F, Chen X, Liu Z, Li S, Mo Z and
Fang X: Expression and clinical significance of Beclin-1 in gastric
cancer tissues of various clinical stages. Oncol Lett.
11:2271–2277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Song H, Xia SL, Liao C, Li YL, Wang YF, Li
TP and Zhao MJ: Genes encoding Pir51, Beclin 1, RbAp48 and aldolase
b are up or down-regulated in human primary hepatocellular
carcinoma. World J Gastroenterol. 10:509–513. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Al-Shenawy HA: Expression of Beclin-1, an
autophagy-related marker, in chronic hepatitis and hepatocellular
carcinoma and its relation with apoptotic markers. APMIS.
124:229–237. 2016. View Article : Google Scholar : PubMed/NCBI
|
